Biotech Values

[ghmm]

If you follow Dew's advice on DNDN, you will have lost on a huge upcoming opportunity.

After reading the board for a couple months now I think I get the general strategy that Dew takes. I can't speak for him but from my perspective it is almost like a Warren Buffet Biotech strategy (if he invested in Biotech which he doesn't). Buy value, Don't swing for the fences, know what you invest in well a corollary may be when you are sure invest heavily (OK this one he has pretty much stated) and buy for the longer term.

I can't say I am innocent of not taking risks but I learned from some past mistakes. I think even if Provenge gets approved without needing additional data it fails as a "Value Biotech" at this stage so would be speculative. I for one am staying away. If it succeeds and pays off big congrats, I'll wait for the next pitch since no strike gets called for taking a pitch even if it is right down the middle (DNDN at best is on the corner) :).